Dr. Emily McDonald is a member of the AOC and Co-Chair of the ACT Communications Working Group. She is an early career researcher at McGill University and the Scientific Director of the Canadian Deprescribing Network. She has published >110 peer-reviewed manuscripts in journals such as NEJM, JAMA Network, and BMJ (including 7 RCTs). She has received ~$4M in funding for the conduct of RCTs in medication appropriateness and optimal treatment of infectious diseases. She has supervised >30 HQP. She was the recipient of the McGill Department of Medicine Early Career Investigator award (2020) and the Canadian Society of Internal Medicine New Investigator award (2017).